Ellington Management Group’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
Sell
-59
Closed -$80K 494
2014
Q2
$80K Buy
+59
New +$80K 0.04% 421